186 results on '"Miraglia C"'
Search Results
2. T04.01.12 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE SETTING: AN EXPERIENCE IN NORTH – EAST ITALY POPULATION
3. T02.01.20 SEROLOGY AS A DIAGNOSTIC TOOL FOR HELICOBACTER PYLORI INFECTION AND ASSOCIATED CHRONIC INFLAMMATION OF THE STOMACH: A POPULATION STUDY ON 524 PATIENTS
4. T01.01.24 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: A 8 YEARS POPULATION STUDY IN NORTHERN ITALY
5. T02.01.7 IS HELICOBACTER PYLORI CURE A LONG-LIFE STRATEGY? A 25 YEARS SURVEY ON 693 PATIENTS
6. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY
7. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY
8. T01.02.19 IS IT POSSIBILE TO WITHDRAW PPIS THERAPY IN GERD PATIENTS? A PROSPECTIVE STUDY ON 216 PATIENTS USING A SECOND GENARTION BARRIER DRUG
9. OC.08.6 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE: NON-INVASIVE APPROACH FOR THE FRAMING OF INTESTINAL DISEASES
10. T04.02.15 OCCURRENCE OF DIVERTICULAR DISEASE IN COLORECTAL CANCER SCREENING: A 3-YEAR STUDY ON 2,104 PATIENTS
11. T06.02.16 CANCER ADENOMAS FOUND DURING 15 YEARS OF SCREENING IN THE ALTO VICENTINO AREA (NORTH-EAST ITALY)
12. T01.01.16 CORRELATION BETWEEN SERUM GASTRIC BIOMARKERS AND HISTOLOGICAL PICTURES OF H. PYLORI INFECTION AND ATROPHIC GASTRITIS: A POPULATION STUDY ON 1,122 PATIENTS
13. OC.08.4 RISK FACTORS FOR ENDOSCOPIC SEVERITY OF DIVERTICULAR DISEASE OF THE COLON AND ITS OUTCOME: A REAL-LIFE CASE-CONTROL STUDY
14. Nutrition and lipidomic profile in colorectal cancers
15. Evaluating Blood Bank Fellow Competency–One Approach
16. RBC Exchange Experience
17. Suspected Transfusion Reactions Associated with an Increase in Respiratory Rate
18. P.01.16 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: AN 11 YEARS POPULATION STUDY
19. P.03.8 EPIDEMIOLOGY OF PANCREATIC CANCER: A POPULATION-BASED STUDY IN NORTH-EAST OF ITALY
20. P.02.27 ENVIRONMENTAL FACTORS (DIVORCE, JOB CHANGING, NIGHT SHIFT CHANGE): CRITICAL ROLE IN IBS OUTCOME. A STUDY ON 110 CONSECUTIVE PATIENTS
21. P.01.25 CAN A NON-INVASIVE TEST PREDICT THE RESULTS OF PH-IMPEDANCE? PROSPECTIVE STUDY OF A COHORT OF PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD
22. P.03.2 THE ROLE OF MMP9 AND HIF1 EXPRESSION IN TUMOR-INFILTRATING LYMPHOCYTES (TIL) IN PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
23. P.02.29 LONG-TERM EFFICACY OF RIFAXIMIN TO MANAGE THE SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
24. P.02.25 RISK FACTORS FOR COLONIC DIVERTICULOSIS: A STUDY IN PRIMARY CARE SETTING
25. OC.10.1 NOVEL MII-PH PARAMETERS ARE ABLE TO DISTINGUISH PATIENTS WITH GERD AMONG SUBJECT WITH EXTRA-ESOPHAGEAL SYMPTOMS
26. PC.01.2 ATROPHIC GASTRITIS IN ALL-CAUSE UPPER GASTROINTESTINAL ENDOSCOPY AT A TERTIARY ENDOSCOPIC CENTER: SEVERITY ACCORDING TO THE OLGA STAGING SYSTEM
27. P.01.31 A COMPARISON OF DIFFERENT TREATMENTS FOR SYMPTOMATIC REFLUX ESOPHAGITIS: A REAL-LIFE STUDY
28. P.01.24 GASTRIC FUNCTION MARKERS: BECAUSE ANTIBODIES ARE NOT ENOUGH IN THE EVALUATION OF AUTOIMMUNE GASTRITIS
29. P.03.9 ENVIRONMENTAL AND METABOLIC RISK FACTORS OF PANCREATIC ADENOCARCINOMA: A RETROSPECTIVE COHORT STUDY
30. P.05.16 APPROPRIATENESS OF UPPER ENDOSCOPY OUTPATIENT PRESCRIPTIONS IN A HIGH-VOLUME ENDOSCOPIC UNIT
31. P.06.19 GASTROENTEROLOGY MADE EASY: AN INNOVATIVE STRATEGY FOR A NATIONAL CAMPAIGN TO RAISE PUBLIC AWARENESS
32. OC.05.6 THE PROGNOSTIC VALUE OF A NEW ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE: DICA (DIVERTICULAR INFLAMMATION AND COMPLICATION ASSESSMENT)
33. Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study
34. P.01.30 THE USE OF PROTON-PUMP INHIBITORS (PPI) REDUCES THE FREQUENCY OF ENDOSCOPICALLY SIGNIFICANT LESIONS (ESL) IN ALL-CAUSE UPPER GASTROINTESTINAL ENDOSCOPY
35. P.06.10 NATURAL HISTORY OF GASTRIC ULCER IN A 25 YEARS FOLLOW-UP: ROLE OF HELICOBACTER PYLORI INFECTION AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
36. P.01.22 REFLUX ESOPHAGITIS AFTER H.P. ERADICATION: THE ROLE OF GASTRIC ACID SECRETION
37. P.01.29 GASTRIC ULCER: RISK FACTORS, HELICOBACTER PYLORI INFECTION AND NSAIDS USE IN A SAMPLE OF 256 PEOPLE
38. P.06.20 GERD DIAGNOSIS IN 340 PATIENTS WITH ATYPICAL OR EXTRA-ESOPHAGEAL SYMPTOMS BY USING A NON INVASIVE SURROGATE TEST
39. P.06.24 HISTOLOGICAL GHRELIN EXPRESSION CORRELATES WITH ECL PROLIFERATION AND CHROMOGRANIN A IMMUNOEXPRESSION: A COMPARATIVE STUDY BETWEEN ATROPHIC AND NON-ATROPHIC GASTRITIS
40. P.06.23 EARLY GERD RELAPSE: A PROSPECTIVE ONE YEAR STUDY BY MEANS OF A NON-INVASIVE SURROGATE TEST
41. P.01.12 FREQUENCY OF DIAGNOSIS OF ATROPHIC GASTRITIS IN A PRIMARY CARE SETTING: A POPULATION STUDY ON 10,000 PEOPLE
42. P.01.25 THE RELATIONSHIP BETWEEN CHRONIC ATROPHIC GASTRITIS AND VITAMIN B12 AND FERRITIN SERUM LEVELS: A CLINICAL STUDY ON FUNCTIONAL ATROPHY
43. P.06.14 EFFECTIVENESS AND SAFETY OF PYLERA ® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY
44. P.01.19 HOMOCYSTEINE IN CHRONIC ATROPHIC GASTRITIS: A STUDY ON IMMUNOHISTOCHEMICAL PATTERNS IN GASTRIC MUCOSA
45. P.06.30 RISK FACTORS FOR ONSET OF ESOPHAGITIS IN A LONG 15 YEARS FOLLOW-UP
46. OC.05.3 HOW CAN WE MEASURE ACID SECRETION IN THE SINGLE PATIENT? A VALIDATED NON-INVASIVE SURROGATE TEST COMPARED WITH MAXIMAL ACID OUTPUT IN 600 PEOPLE
47. P.06.26 RISK FACTORS IN GERD: A COMPARATIVE STUDY WITH DYSPEPTIC SUBJECTS ON 2300 PEOPLE IN A PRIMARY CARE SETTING
48. P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients
49. P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination
50. P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.